Clinical benefit from palbociclib, letrozole and goserelin combination therapy for sweat gland carcinoma with neuroendocrine differentiation (<scp>SCAND</scp>)-Reference-Cited by-同舟云学术

Clinical benefit from palbociclib, letrozole and goserelin combination therapy for sweat gland carcinoma with neuroendocrine differentiation (SCAND)

Published:2024-08-08 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Tzoumpa Sofia¹^ORCID,Bejar Claudia¹,Villette Béatrice¹,Louveau Baptiste²³,Zelek Laurent⁴,Martin Antoine⁵,Briard Ophélie⁶,Bitout Djamela⁷,Caux Frédéric¹^ORCID,Battistella Maxime³⁸,Mourah Samia²³,Maubec Eve¹⁹^ORCID

Affiliation:

1. Department of Dermatology Avicenne University Hospital, AP‐HP, Sorbonne‐Paris‐Nord University Bobigny France

2. Department of Tumor Genomics and Pharmacology Saint‐Louis University Hospital, AP‐HP, Paris‐Cité University Paris France

3. INSERM, UMR‐S 976 Paris France

4. Department of Medical Oncology Avicenne University Hospital, AP‐HP, Sorbonne‐Paris‐Nord University Bobigny France

5. Department of Pathology Avicenne University Hospital, AP‐HP, Sorbonne‐Paris‐Nord University Bobigny France

6. IRHE Bobigny France

7. Department of Dermatology Delafontaine Hospital Saint‐Denis France

8. Department of Pathology Saint‐Louis University Hospital, AP‐HP, Paris‐Cité University Paris France

9. INSERM UMR1124, Campus Saint‐Germain‐Des‐Prés Université Paris Cité Paris France

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20276

Reference9 articles.

1. Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis

2. Sweat Gland Carcinoma With Neuroendocrine Differentiation of the Areola as a Potential Clinicopathologic Mimicker of Male Breast Carcinoma and Syringocystadenocarcinoma Papilliferum

3. Recurrent GATA3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation

4. A case of sweat‐gland carcinoma with neuroendocrine differentiation;Koizumi S;Dermatol Reports,2022

5. An Update on Endocrine Mucin-producing Sweat Gland Carcinoma